Entera Bio receives 180-day Nasdaq extension to June 24, 2024 to meet $1.00 bid price rule

Entera Bio Ltd.

Nasdaq granted 180-day extension on Dec 27, 2023; new compliance deadline is June 24, 2024.
Must maintain closing bid price of at least $1.00 for 10 consecutive business days.
Company may pursue reverse stock split to regain compliance.
Failure to comply by June 24, 2024 could lead to delisting; trading continues for now.
Extended period has no immediate effect on listing or trading under symbol ENTX.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.